1 & 2 February 2023
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
18 January - 17 February 2023
Online event and networking
Pharmapack Awards 2023
Launched in 1997, the Pharmapack Awards celebrate the latest innovations from packaging companies within the drugs, medical devices, health products and veterinary drugs sectors.
The Pharmapack Awards recognise innovations that have improved drug efficacy, user safety or reduced the environmental impact.
The Pharmapack Awards consider entries in 2 segments:
Health Product Awards
The Pharmapack Health Product Awards seek to recognise excellence in commercialised packaging or drug delivery solutions from pharmaceutical, veterinary, biopharma or OEM companies. Entries in this category will be evaluated by a Jury of independent pharmacists, physicians, and experts in patient-centric and sustainable packaging..
Who can apply?
Pharmaceutical, veterinary, biopharma or OEM companies - you can also co-apply with your manufacturer or packaging developer if the innovation is a collaborative one. That way, both companies get recognized for their work!
The Jury will consider entries that have received market authorization from a qualified national authority for a newly commercialized medicinal product after January 2022. The entry must feature an innovative packaging or drug delivery solution. To enter, complete the form at the bottom of this page with as much detail as possible. You will have the option to include images, documents, and other media to support your entry.
Entries for the 2023 Pharmapack Awards are closed.
For 2023, we have entries across three categories:
Patient-Centric Design Award
Recognising innovative design of packaging or drug delivery solutions which prioritise patient experience and adherence,for improved health outcomes.
Design Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method, or novelty to the market? Does it offer a competitive advantage?
Patient Experience: Does the entry improve patient adherence, safety, experience, and outcomes? Does it reduce dosing errors, is the patient information created with the user in mind, is it readable and accessible for all patients? Is it easy for the patient to recycle the product?
Ease of Use:
Does the entry promote easy and safe administration by patients or HCPs? Is it easy to open and re-seal, is it portable, intuitive, discrete, and ergonomically designed?
Eco-Design Award
Recognising products and solutions which prioritise recyclability, environmental awareness, and a reduced carbon footprint.
Carbon footprint: Does the product demonstrate a significant decrease to the environmental impact vs other products on the market?
Sustainability: Is the new product more sustainable or easier to recycle than existing solutions on the market? Does it demonstrate a reduced use of plastic, or if plastics are used, are they chemically compatible or jointly processable during recycling? Are labels and pigments minimized? If the product is composed of several materials, can they be easily separated during recycling processes?
Animal Health
Recognises products and solutions which improve or enhance health outcomes and the well-being of animals.
Design Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method, or novelty to the market? Does it offer a competitive advantage?
Ease of Use: Does the entry promote easy and safe administration by farmers, veterinarians, and pet owners? Is it easy to open and re-seal, is it portable, intuitive, hygienic, and ergonomically designed?
Experience and Outcomes: Does the entry improve adherence, safety, experience, and outcomes for animals? Does it reduce dosing errors, is it easy to administer, does it reduce stress for the animal?
Entries for the 2023 Pharmapack Awards are closed
The Health Product Awards are supported by:
Exhibitor Innovation Awards
The Exhibitor Innovation Awards allow those exhibiting at Pharmapack Europe 2023 with a corresponding Innovation Package to present innovative approaches to packaging materials, primary or secondary packaging, cool chain and logistics, sustainability initiatives and drug delivery solutions.
We welcome entries with a timeline for launch up until the end of 2024, in either proof of concept or prototype stage. Entries in this category
will be evaluated by a Jury of packaging and drug delivery thought-leaders with a wealth of industry experience.
Entries for the 2023 Pharmapack Awards are closed.
Recognising innovative approaches to safe and efficacious drug delivery, including but not limited to; ophthalmic, parenteral, oral, respiratory, transdermal and topical drug delivery solutions.
• Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method or novelty to the market?
• Patient Experience: Does the entry improve patient adherence, experience and outcomes?
• Ease of Use: Does the entry promote easy and safe administration by patients or HCPs?
• Sustainability: IIs the product reusable, ecologically designed or easily recyclable? Does it demonstrate a clear reduction in carbon footprint?
• Added Value: Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability or a collaborative approach to development?
Recognising innovation in technologies, products, materials, and services relating to primary, secondary and tertiary packaging solutions for finished drug forms which safeguard products from manufacture to point of use. Including, but not limited to; vials, syringes, ampoules, bottles, container liners, flasks, tubes, blister packs, tamper-proof packaging, senior-friendly packaging, child-resistant packaging, and smart packaging.
• Innovation: Does the entry meet an unmet need, or introduce a new idea, approach, method or novelty to the market?
• Patient Experience: Does the entry improve patient adherence, experience and outcomes?
• Fit for Purpose: Does the entry adequately protect the drug product for which it is designed? Does it prevent minimal extractable and leachable risk?
• Sustainability: Is the product reusable, ecologically designed or easily recyclable? Does it demonstrate a clear reduction in carbon footprint?
• Added Value: Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility and adaptability?
Recognising innovation in technologies, products, materials, initiatives, and services related to the promotion of sustainable primary, secondary, or tertiary packaging solutions for finished drug forms, which safeguard products from manufacture to point of use. Including, but not limited to; containers, cartons, pallets, blister cards, shrink-wrapped bundles, labelling systems, tamper-proof packaging, senior-friendly packaging, child-resistant packaging, and smart packaging solutions.
• Innovation: Does the entry meet an unmet need, or introduce a new idea, approach, method, or novelty to the market?
• Patient Experience: Is the product easily recyclable for HCPs or for patients? Does it improve the patient experience?
• Fit for Purpose: Does the entry adequately protect the drug product for which it is designed? Does it offer benefits for branding and product display?
• Sustainability: Is the product reusable, ecologically designed or easily recyclable? Does it reduce the use of plastics and/or other waste? Does it present a demonstrable reduction in carbon footprint?
• Added Value: Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability, or a collaborative approach to development?
Recognising innovation in pharmaceutical packaging machinery, technology, and equipment. This category seeks to recognise both stand alone and integrated solutions which promote efficiency, cost effectiveness and sustainable approaches to the assembly and packaging of pharmaceutical products.
• Innovation: Does the entry meet an unmet need, or introduce a new idea, approach, method, or novelty to the market?
• Fit for Purpose: Does the entry offer efficient and cost-effective solutions? Does it prioritise packaging design?
• Sustainability: Does the entry promote a sustainable approach?
• Added Value: Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability or a collaborative approach to development?
Innovation in technologies, products, processes, and services for ensuring the safe handling and tracking of drug substances, raw materials, and finished drug products including, but not limited to, supply chain, audits, temperature-controlled logistics, transport services, track and trace, shipping containers, and distribution channels.
• Innovation: Does the entry meet an unmet need, or introduce a new idea, approach, method or novelty to the market?
• Patient Experience: Does the entry improve patient adherence, experience and outcomes?
• Fit for Purpose: Does the entry adequately protect the drug product for which it is designed?
• Sustainability: Does the entry exhibit a sustainable approach or minimise waste? Does it demonstrate a clear reduction in carbon footprint?
• Added Value: Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability or a collaborative approach to development?
/HLN21PPE-Footer-French-Government-goahead.png)
/HLN20PPE-SP-285x55_Partner_PharmaTech.png)
As a part of our continued commitment to the sustainability of our event, 100% of the electricity used within Paris Expo venue is generated from a renewable origin.
To learn more about this please click here.
Our event has also been successfully accredited with the prestigious ISO 20121 Standard for Sustainable Event Management.
To learn more about this please click here.
Running Pharmapack Europe gives us lots of opportunities to improve our impacts socially, environmentally, and economically in our host city.
We want to make a difference, and here’s how we do it.